BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22579303)

  • 1. Translating the Rosetta Stone of N-acetylcysteine.
    Dean OM; Bush AI; Berk M
    Biol Psychiatry; 2012 Jun; 71(11):935-6. PubMed ID: 22579303
    [No Abstract]   [Full Text] [Related]  

  • 2. Glutamatergic modulation of auditory information processing in the human brain.
    Gunduz-Bruce H; Reinhart RM; Roach BJ; Gueorguieva R; Oliver S; D'Souza DC; Ford JM; Krystal JH; Mathalon DH
    Biol Psychiatry; 2012 Jun; 71(11):969-77. PubMed ID: 22036036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude.
    Oranje B; Gispen-de Wied CC; Westenberg HG; Kemner C; Verbaten MN; Kahn RS
    Int J Neuropsychopharmacol; 2009 Jul; 12(6):823-32. PubMed ID: 19154656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients.
    Lavoie S; Murray MM; Deppen P; Knyazeva MG; Berk M; Boulat O; Bovet P; Bush AI; Conus P; Copolov D; Fornari E; Meuli R; Solida A; Vianin P; Cuénod M; Buclin T; Do KQ
    Neuropsychopharmacology; 2008 Aug; 33(9):2187-99. PubMed ID: 18004285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine effects on brain function--simultaneous fMRI/EEG during a visual oddball task.
    Musso F; Brinkmeyer J; Ecker D; London MK; Thieme G; Warbrick T; Wittsack HJ; Saleh A; Greb W; de Boer P; Winterer G
    Neuroimage; 2011 Sep; 58(2):508-25. PubMed ID: 21723949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical N-acetylcysteine for lamellar ichthyosis.
    Redondo P; Bauzá A
    Lancet; 1999 Nov; 354(9193):1880. PubMed ID: 10584733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prothrombin index prolongation due to N-acetylcysteine during the treatment of Amanita phalloides poisoning].
    Fernández de Larrea C; Lozano M; Castro P; Nicolás JM
    Med Clin (Barc); 2008 Nov; 131(18):717-8. PubMed ID: 19087832
    [No Abstract]   [Full Text] [Related]  

  • 8. [N-Acetylcysteine--a new possibility in the therapy of hepatic failure].
    Isoniemi H; Pöyhiä R
    Duodecim; 1999; 115(4):361-2. PubMed ID: 11830884
    [No Abstract]   [Full Text] [Related]  

  • 9. N-acetylcysteine administration in the critically ill.
    Walsh TS; Lee A
    Intensive Care Med; 1999 May; 25(5):432-4. PubMed ID: 10401934
    [No Abstract]   [Full Text] [Related]  

  • 10. [N-Acetylcysteine: new possibilities to use an old substance].
    Ahola T; Lapatto R
    Duodecim; 1999; 115(4):375-9. PubMed ID: 11830885
    [No Abstract]   [Full Text] [Related]  

  • 11. N-acetylcysteine improves EEG measures of auditory deviance detection and neural synchronization in schizophrenia: A randomized, controlled pilot study.
    Yang YS; Davis MC; Wynn JK; Hellemann G; Green MF; Marder SR
    Schizophr Res; 2019 Jun; 208():479-480. PubMed ID: 30712814
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acetylcysteine in chronic obstructive pulmonary disease. Secretolytic, antioxidant or placebo?].
    Randerath W; Galetke W
    Med Monatsschr Pharm; 2003 Nov; 26(11):375-8. PubMed ID: 14652922
    [No Abstract]   [Full Text] [Related]  

  • 13. N-acetyl-cysteine treatment for polycystic ovary syndrome.
    Kilic-Okman T; Kucuk M
    Int J Gynaecol Obstet; 2004 Jun; 85(3):296-7. PubMed ID: 15145276
    [No Abstract]   [Full Text] [Related]  

  • 14. N-acetylcysteine modulates hallucinogenic 5-HT(2A) receptor agonist-mediated responses: behavioral, molecular, and electrophysiological studies.
    Lee MY; Chiang CC; Chiu HY; Chan MH; Chen HH
    Neuropharmacology; 2014 Jun; 81():215-23. PubMed ID: 24534112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of N-acetylcysteine.
    Kelly GS
    Altern Med Rev; 1998 Apr; 3(2):114-27. PubMed ID: 9577247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deviance-elicited changes in event-related potentials are attenuated by ketamine in mice.
    Ehrlichman RS; Maxwell CR; Majumdar S; Siegel SJ
    J Cogn Neurosci; 2008 Aug; 20(8):1403-14. PubMed ID: 18303985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of quetiapine on auditory P300 response in patients with schizoaffective disorder: preliminary study.
    Korostenskaja M; Dapsys K; Siurkute A; Dudlauskaite A; Pragaraviciene A; Maciulis V; Kähkönen S
    Ann Clin Psychiatry; 2009; 21(1):49-50. PubMed ID: 19239832
    [No Abstract]   [Full Text] [Related]  

  • 18. [N-acetylcisteine in Amanita phalloides poisoning].
    Mas A; Nogué S
    Med Clin (Barc); 2009 Oct; 133(12):486; author reply 487. PubMed ID: 19359014
    [No Abstract]   [Full Text] [Related]  

  • 19. The antioxidant N-acetylcysteine does not delay disease onset and death in a transgenic mouse model of amyotrophic lateral sclerosis.
    Jaarsma D; Guchelaar HJ; Haasdijk E; de Jong JM; Holstege JC
    Ann Neurol; 1998 Aug; 44(2):293. PubMed ID: 9708560
    [No Abstract]   [Full Text] [Related]  

  • 20. [N-acetylcysteine in septic shock].
    Ellouze O; Frikha N; Ouerghi S; Mestiri T; Salah Ben Ammar M
    Tunis Med; 2011 Oct; 89(10):738-44. PubMed ID: 22076894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.